We serve Chemical Name:(S)-Benzyl 3-hydroxy-1-(methylamino)-1-oxopropan-2-ylcarbamate CAS:19647-68-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(S)-Benzyl 3-hydroxy-1-(methylamino)-1-oxopropan-2-ylcarbamate
CAS.NO:19647-68-8
Synonyms:(S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate;benzyl N-[(2S)-3-hydroxy-1-(methylamino)-1-oxopropan-2-yl]carbamate
Molecular Formula:C12H16N2O4
Molecular Weight:252.26600
HS Code:2924299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:87.66000
Exact Mass:252.11100
LogP:0.80150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,benzyl N-[(2S)-3-hydroxy-1-(methylamino)-1-oxopropan-2-yl]carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzyl N-[(2S)-3-hydroxy-1-(methylamino)-1-oxopropan-2-yl]carbamate Use and application,(S)-Benzyl (3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)carbamate technical grade,usp/ep/jp grade.
Related News: The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. Benzene, 1,2,4-tributyl-3,5,6-triethyl- manufacturers To make Zynteglo, the stem cells taken from the patient’s blood are modified by a virus that carries working copies of the beta-globin gene into the cells. N1-{5-[(9-Fluoro-4,5-dihydrobenzo[2,3]thiepino[4,5-d][1,3]thiazol-2-yl)amino]pentyl}-2-methoxy-5-methyl-1-benzenesulfonamide suppliers After speaking to iRhythm on Tuesday, J.P. Morgan analysts wrote we shouldn’t expect an update on reimbursement before the release of the Physician Fee Schedule proposed rule in July/August. acetic acid-(1-bromo-3,3-dichloro-propyl ester) vendor & factory.
